What is Alodokter?
Founded in 2014 and headquartered in Jakarta, Alodokter operates as a comprehensive telemedicine healthcare software services provider. The platform bridges the gap between patients and medical professionals, offering a suite of digital tools that facilitate remote consultations, health information access, and integrated medical services. In an era where digital health transformation is critical, Alodokter has established itself as a vital infrastructure component for the Indonesian healthcare ecosystem, effectively digitizing the patient-provider relationship through a user-centric mobile interface.
How much funding has Alodokter raised?
Alodokter has raised a total of $42.5M across 3 funding rounds:
Series A
$2.5M
Series B
$7M
Series C
$33M
Series A (2016): $2.5M with participation from 500.com and Golden Gate Ventures
Series B (2017): $7M led by SoftBank Corp
Series C (2020): $33M supported by Dayli Partners, Softbank Ventures Asia, Golden Gate Ventures, MDI Ventures, Philips, Heritas, Hera Capital, and Sequis Life
Key Investors in Alodokter
Golden Gate Ventures
Golden Gate Ventures is a leading venture capital firm specializing in early-stage investments across Southeast Asia, focusing on high-growth sectors such as consumer internet and fintech.
MDI Ventures
MDI Ventures is a global multi-stage venture capital firm that drives digital transformation by investing in local founders and startups, particularly within the Indonesian technology ecosystem.
Hera Capital
Hera Capital is a Singapore-registered fund management company that provides growth capital to small-to-mid sized companies, emphasizing impact investments in technology and sustainable solutions.
What's next for Alodokter?
Looking ahead, Alodokter is poised to leverage its major enterprise-level funding to accelerate product innovation and deepen its market penetration. The strategic focus will likely center on enhancing the platform's AI-driven diagnostic capabilities and expanding its network of healthcare partners. By prioritizing scalable technology and operational excellence, the company aims to solidify its dominance in the regional health-tech space, ensuring that it remains at the forefront of the digital health revolution in Southeast Asia.
See full Alodokter company page
